An average of 36 seconds per broadcast is all that election coverage has warranted on local evening news in nine top Midwestern markets since Labor Day, a study released Thursday found.The five-state analysis by the University of Wisconsin-Madison’s NewsLab looked at 30-minute evening news broadcasts on 36 stations in nine top Midwestern television markets.
Madison: How much election coverage do you want to see in your evening newscast? A new study by the University of Wisconsin says you’re not getting enough.
The study was conducted by the University of Wisconsin’s Newslab. Researchers looked at all the primetime newscasts in the month after Labor Day in 9 cities throughout the Midwest.
Q: Why does baby babble sound the same in any language?
A. Actually, that isn’t necessarily the case, says Jenny Saffran, who studies infant and child language at UW-Madison’s Waisman Center.
The executive producer of Nova, PBS�s popular science show, will be interacting with students and faculty at the University of Wisconsin next week.
Democratic Gov. Jim Doyle unveiled a new job-creation initiative Wednesday in an effort to address the state�s growing need for workers capable of filling jobs in emerging high-tech industries.
Free stem cells for all? Possibly, now that the US Patent and Trademark Office is re-examining key patents on human embryonic stem cells (ESCs) that some say have been stifling stem cell research.
A study from the University of Wisconsin’s NewsLab to be released later today found that Midwest TV stations in nine markets aired an average of 36 seconds of election coverage in a typical 30-minute’s worth of news broadcast, with only foreign policy and “unintentional injury” stories getting less airplay.
Wisconsin received $387.7 million in grants from the National Institutes of Health in 2005, down almost 1 percent from the $391.9 million the state received in 2004.
As part of his plan to provide $5 million to stem-cell research companies, Gov. Jim Doyle presented $1 million Tuesday to a new company aiming to generate blood products from human embryonic stem cells.
Doyle presented the financial package to founders of Stem Cell Products Inc., started by research pioneer and University of Wisconsin biology professor James Thomson, who isolated the first embryonic stem-cell line.
Gov. Jim Doyle announced another pledge for stem cell research Tuesday, giving $1 million to a stem cell start-up company founded by three UW-Madison researchers including James Thomson, the professor who pioneered stem cell research and isolated the first embryonic stem cell.
Stem Cell Products, Inc., run by Thomson and fellow UW-Madison researchers Igor Slukvin and Dong Chen, will begin research on a process that derives red blood cells and platelets from embryonic stem cells. According to Doyle, platelets are in short supply and the U.S. military frequently flies wounded soldiers to Germany in order to perform blood transfusions.
Stem cell pioneer James Thomson and two other University of Wisconsin-Madison scientists have started a company that aims to grow platelets and red blood cells from embryonic stem cells.
The company, Stem Cell Products Inc., has the chance to have the first therapeutic product based on human embryonic stem cells to make it to the marketplace, said Bob Palay, managing member of Tactics II Ventures LP, a Wisconsin venture capital firm that invested in and helped start the company.
Scientists studying 25 years of satellite images have found that the frequency of hurricanes in the Atlantic Ocean was substantially reduced in years when sandstorms and trade winds combined to send millions of tons of dust streaming west over the sea from the Sahara Desert. The correlation, measured by a team of scientists from the University of Wisconsin and federal agencies, is described in the current issue of Geophysical Research Letters. Layers of dry, dusty air, moving at up to 50 miles an hour, can disrupt tropical storms in several ways. The research shows that many factors can affect hurricane seasons, complicating efforts to determine whether global warming has played a role recently, some of the authors said.
UW-Madison stem-cell pioneer James Thomson and his colleagues have discovered a way to use human embryonic stem cells to create components of human blood – products, they say, that are safe and can eventually be used to help a range of patients, from those with anemia caused by chemotherapy to soldiers wounded in battle.
Quoted: Charles Czuprynski of the University of Wisconsin-Madison School of Veterinary Medicine.
The recent out-of-state challenges, including one from California, to stem cell patents held by the Wisconsin Alumni Research Foundation (WARF) lack merit and underscore the need for serious patent reform in the United States.
WASHINGTON – Dust storms swirling out of Africa’s Sahara Desert may help reduce hurricane activity in the Atlantic Ocean, a new study suggests.
A new start-up business gives hope to those who need blood transfusions. UW-Madison researcher James Thomson and two other scientists started the Stem Cell Products, Incorporated.
Stem cell research pioneer James Thomson says he’s started a company to create blood products from human embryonic stem cells. Ã? Governor Jim Doyle appeared with Thomson at a news conference to announce the state was awarding a 250-thousand dollar grant and 750-thousand dollar loan to the company, Stem Cell Products, Incorporated.
Gov. Jim Doyle today gave $1 million in state funding to a Madison-based firm headed by UW-Madison stem cell researcher James Thomson.
Doyle announced the combination of state grants and loans to Stem Cell Products, Inc., the second start-up firm headed by Thomson, at a news conference this morning.
The firm is developing the use of embryonic stem cells in producing components of human blood cells, such as platelets that assist in blood clotting.
WASHINGTON – Hundreds of miles from the fierce gubernatorial debate over stem cells, leading scientists who work in public policy vented their frustration Monday with a federal government they believe fundamentally misunderstands the issue of embryonic stem cell research.
“I always thought members of Congress should pass a scientific literacy test before they take office,” said Donna Shalala, former UW-Madison chancellor and current president of the University of Miami at Florida.
When John Lemke puts on a costume to become a headless ventriloquist this month, he’s not just celebrating Halloween. The Wisconsin Historical Museum’s publicist is competing for your attention, and your time.
….Eight Madison tourist sites this month are beginning a collaboration, dubbed M8, to increase their visibility by presenting themselves as one. Lemke heads the charge; other participants are the Wisconsin Veterans Museum, Madison Children’s Museum, Madison Museum of Contemporary Art, Chazen Museum of Art, UW Geology Museum, Monona Terrace and Olbrich Botanical Gardens.
For all of the appropriate and necessary attention given the University of Wisconsin for its role in the research and development of the science driving the biotechnology sector of our state’s economy, one of the great under appreciated stories is the growing number of businesses producing the drugs and devices that research is spawning.
Researchers at UW-Madison have discovered a genetic switch that may prove useful in controlling the formation of blood vessels, a process called angiogenesis.
A year ago, bird flu was in the news nearly every day. The drumbeat of a pandemic threat was growing louder. Health officials hurried preparation plans.
Today, bird flu seems more like the punchline of a joke.
But experts say it remains just as dangerous – and just as able to cause a worldwide outbreak of flu like none seen since 1918, when as many as 50 million people died.
“The reality is this virus is continuing to spread,” said Christopher Olsen, a virologist at the UW-Madison School of Veterinary Medicine. “It’s continuing to infect birds. It’s continuing to kill human beings.”
An international meeting in Madison of environmental health scientists has given birth to a new association that will likely play a key role in addressing such worldwide issues as avian flu, industrial agriculture and climate change-related diseases.
The new group is called The International Association for Ecology and Health.
Long known for its state-of-the art research facilities, the University of Wisconsin has historically made a place for itself in addressing worldwide issues. Continuing in that tradition, three top UW researchers addressed alumni who have since become CEOs around the nation Saturday at the Fluno Center.
ââ?¬Å?We heard from people today that are attacking some of the biggest problems we have, in industry and society,ââ?¬Â Chairman and CEO of Rockwell Automation Keith D. Nosbusch said at Saturdayââ?¬â?¢s summit. ââ?¬Å?What theyââ?¬â?¢re working on here at Wisconsin has a direct connection to the future.ââ?¬Â
University of Wisconsin College of Agricultural and Life Sciences professor Michael Carter will administer a $10 million, five-year federal program aiming to curtail poverty in third-world nations.
The program, called the Assets and Market Access Collaborative Research Support Program, is part of a United States Agency for International Development effort addressing global poverty.
Patents are big business and big philanthropy at the Wisconsin Alumni Research Foundation, which helps keep UW-Madison in the top tier of research universities.
Since its founding in 1925, WARF, which manages all intellectual property for the university, has donated approximately $800 million to UW-Madison from income on licensing university-based patents, said Jill Ladwig, senior writer for WARF.
Incumbent Gov. Jim Doyle and his Republican challenger U.S. Rep. Mark Green, butted heads for a second time Friday night in Milwaukee, debating a wide range of social issues including stem cell research, abortion, the death penalty and education.
Stem cell research proved to be the hot topic of the debate, with Doyle saying, “There is no issue on which we differ [more] fundamentally.”
Madison, Wis. – When scientists look back at this early period in human embryonic stem cell discovery, they might regret the hype surrounding this controversial research, but they won’t be able to accuse the man who derived stem cells from embryos of contributing to it.
A broad-based initiative to spur commercialization in Toronto, whether Wisconsin can compete with alternative fuels and China’s market for biotechnology products are just three of the topics to be covered this week at a conference in Waukesha.
Former Wisconsin Public Service Commission chairman Ave Bie and representatives from the University of Wisconsin-Madison, Wisconsin Agri-Service Association and BEST Energies Inc. will discuss whether Wisconsin has the tools to lead in the new economy being created from transforming substances like corn and soybeans into fuel.
In an intriguing finding, University of Wisconsin-Madison researchers have unveiled a critical protein that prevents influenza viruses from entering cells, a mechanism that could spark production of anti-viral medications to fight multiple flu strains, including the deadly strain of bird flu that’s circulating globally.
The University of Wisconsin-Madison’s patenting and licensing arm is creating a new position to help create more start-up companies from the school’s technological innovations.
An experimental vaccine being tested at UW Madison could soon make the sneezy, runny-eyed misery of hay fever a thing of the past.
The vaccine involves injections of the allergen itself-ragweed. Traditional allergy treatments can take years to show full benefit. But the experimental treatment takes just six weeks.
A marketable vaccine is still far off. The UW still has to complete testing, along with several other universities, and the drug would need to be approved by the FDA.
Outlining some of the remaining challenges for stem cell researchers, University of Wisconsin-Madison professor James Thomson took the opportunity to inject some realism into the stem cell expectations game before UW-educated executives at a CEO Summit convened by John Morgridge, chairman and former CEO of Cisco Systems.
In the summer of 2005, 67-year-old cancer surgeon John Niederhuber was ready for a new chapter in a career spent hopscotching across the country in academic medicine. His wife had died of breast cancer a few years earlier, and his son would soon head off to college. So when Andrew von Eschenbach, director of the National Cancer Institute (NCI), asked him to join his staff as a deputy director, Niederhuber left his job as a surgery and oncology professor at the University of Wisconsin, sold his house in Madison, and headed to Washington, D.C.
Q: Why do veins appear blue?
A: “Veins are actually not blue, they are red, just like arteries,” says T. Michael Nork, an associate professor in the UW School of Medicine and Public Health. “They are a somewhat darker red because the oxygenated form of hemoglobin found (in) the arterial red blood cells is brighter than the de- oxygenated form in veins.”
(MADISON) The University of Wisconsin-Madison scientist who first grew human embryonic stem cells predicts they will change medicine for the better. However, James Thomson says growing replacement tissue or curing diabetes is, in his words, a ââ?¬Å?long way off.ââ?¬Â
In a speech to the downtown Madison Rotary Club, Thomson said the quickest and most widespread use of embryonic stem cells is likely to be the testing of drugs: making particular human tissues on which pharmaceuticals, like heart drugs, can be tried. He says ultimately there will be safer drugs that get to the market quicker. (5th item.)
A substance that could block the deadly bird flu virus exists right in your body.
It’s a peptide – a very small piece of a protein. But it has managed to block several strains of influenza in tests with cell cultures and mice at the University of Wisconsin-Madison.
You have probably all heard, at one point or another, that UW-Madison scientist Jamie Thomson was the first person in the world to grow human embryonic stem cells. You have also probably heard about the amazing promise that stem cell research has to cure scores of deadly diseases.
University of Wisconsin researchers have discovered a new drug that could help protect people against the avian flu virus.
The California Institute for Regenerative Medicine issued a plan today for how it would spend the $3 billion assigned by the state�s voters to finance stem cell research.
With flu season looming, there is at least some good news from UW-Madison about a potential new treatment – a tiny but powerful protein that blocks a broad number of flu viruses from attaching to and entering host cells.
CHICAGO (Reuters) – A fragment of a human protein that blocks influenza viruses — including avian flu — from attaching to and infecting cells holds promise if laboratory experiments are borne out, researchers said on Wednesday.
Madison, Wis. – Federal health officials may not be saying it, but they are frightened to death of the following scenario: an outbreak of the deadly avian flu virus begins quietly in scattered areas of the country, and spreads before they can get a handle on it – with substantial harm done to public health and the economy.
A potential breakthrough out of UW Madison tonight in the bird flu battle.Researchers there have found a new drug that blocks influenza.� A team of UW scientists say they just happened to stumble across this new drug.
The U.S. Patent and Trademark Office announced Tuesday that it plans to re-examine patents covering research by stem cell leader and UW-Madison scientist James Thomson and other UW-Madison scientistsÃ?¢ââ??‰â?¬Âsupposedly the first researchers in the world to grow and isolate human embryonic stem cells.
The U.S. Patent and Trademark Office announced Tuesday that it intends to review patents for embryonic stem-cell research held by the Wisconsin Alumni Research Foundation.
The United States Patent and Trademark Office has agreed to re-examine the validity of fundamental patents on human embryonic stem cells granted to a scientist at the University of Wisconsin.
The U.S. Patent and Trademark Office will re-examine three key patents on embryonic stem cells held by the Wisconsin Alumni Research Foundation.
MADISON, Wis. – The U.S. Patent and Trademark Office will re-examine patents covering embryonic stem cell discoveries made by University of Wisconsin researchers.
The U.S. Patent and Trademark Office has agreed to re-evaluate the validity of three core stem cell patents held by a Wisconsin foundation that has been accused of strangling U.S. research in the field with sweeping demands for license fees and royalties from other investigators.
THIS IS how far Silas Bernardoni can heave a pumpkin. Imagine him standing on the 50-yard line at Camp Randall. From there, Bernardoni could send the pumpkin clear out of the stadium.
Not by himself, of course. Bernardoni, a senior in engineering at UW-Madison, utilizes a trebuchet – a large catapult-like device that was once employed by invading armies to hurl stones at castle walls.
Mostly obsolete since the 1300s, the trebuchet has of late made something of a comeback, as engineering enthusiasts and others have staged competitions and teachers have learned that the visually stunning trebuchet tosses can get students excited about science.
….Bernardoni has since gained a supporter in UW-Madison Chancellor John Wiley and thinks a world record pumpkin launch may be in reach.
A liner on a 1.5 million-gallon swine manure storage pit at the University of Wisconsin-Madison’s Arlington Agricultural Research Station leaked during the summer, requiring a cleanup of soil beneath the liner and an expensive replacement.
The State Building Commission will consider the $275,000 cost for general fund-supported borrowing on Wednesday morning at the State Capitol, because the low bid came in above the $150,000 limit that can be acted on without commission approval, university officials said.
Name: Phil Pellitteri
Age: 54
Occupation: UW-Extension entomologist
To be honest, when I was a kid, I did collect butterflies. I went to the UW for school and was originally interested in wildlife ecology. I eventually took an introductory course in entomology and basically got interested enough to transfer into the program and got my undergrad and master’s degrees here.
Someday, we may have the lowly fruit fly to thank for a better understanding of neurodegenerative diseases in humans such as Alzheimer’s and Parkinson’s.
A large, long-term study of calorie restriction in rhesus monkeys at the Wisconsin National Primate Research Center has shown that the diet prevents diabetes and may reduce the risk of arthritis and other age-related diseases. The leaner monkey on the left is on the restricted diet, the one on the right is on a normal diet.
An ongoing study at the University of Wisconsin-Madison in which rhesus monkeys are being fed an extremely calorie-restricted diet gives preliminary evidence that the regime prevents age-related diseases
Madison Area Technical College and the UW-Madison announced a $20,000 award by the Focus on Energy program to construct a solar collector testing facility at MATC – just the second of its kind in the U.S.
The lab will join the University of Central Florida’s Solar Energy Center as the only facilities in the country authorized to certify solar panels, which qualifies the homeowners who install them for tax credits and rebates. There is a certification backlog in the U.S.
Issues of supply, security and ecology demand the production of alternative sources of fuel, said the British ambassador to the U.S. in an address at the University of Wisconsin-Madison.
Sir David Manning was in town to hear from a panel of UW-Madison scientists at a private luncheon Friday before giving a public address on “energy security and climate security.”
“If we can find alternative sources of energy that are clean sources of energy, we reduce our dependence on unstable parts of the world,” Manning said. If companies do this, “they will be in the forefront of the new energy technology. They will make a lot of money for it.”
The Epstein-Barr virus, the most common culprit of mono, infects most people and is linked to cancer later in life. Researchers at the UW-Madison McArdle Laboratory for Cancer Research and the German National Research Center for Environmental Health have discovered information about the virus�s lifecycle which could lead to virus-specific, targeted treatments for certain cancers.
